GGrantIndex
Sort

130,381 grants matching hiv

University of Pittsburgh MACS/WIHS CCS

$4,249,415
Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · HL

Operations and Collaborations Center - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)

$4,248,110
Barbara Driver · Westat, Inc. · UM2 · FY2023 · HD

LC: HIV Prevention Trials Network

$4,245,488
Susan H Eshleman · Johns Hopkins University · UM1 · FY2017 · AI

Neuropathogenesis of Retroviral Infections

$4,245,003
Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS

AIDS and Cancer Specimen Resource (ACSR)

$4,244,545
Sylvia Silver · George Washington University · UM1 · FY2019 · CA

Laboratory Center (LC): Microbicide Trials Network

$4,243,008
Charlene Dezzutti · Magee-Women'S Res Inst And Foundation · UM1 · FY2016 · AI

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center

$4,239,147
Joseph B. Margolick · Johns Hopkins University · U01 · FY2020 · HL

Natural History of AIDS Homosexual Men

$4,237,269
Roger Detels · University Of California Los Angeles · U01 · FY2013 · AI

The RCMI Program in Health Disparities Research at Meharry Medical College

$4,236,272
Maria F Lima · Meharry Medical College · U54 · FY2018 · MD

Age-related Tauopathy in HIV-associated Neurocognitive Disorders

$4,235,695
Susan Morgello · Icahn School Of Medicine At Mount Sinai · RF1 · FY2018 · AG

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

$4,235,154
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2020 · HL

AIDS and Cancer Specimen Resource (ACSR)

$4,234,901
Michael Shannon McGrath · University Of California, San Francisco · UM1 · FY2015 · CA

Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy

$4,234,248
Edus Houston Warren · Fred Hutchinson Cancer Center · U01 · FY2025 · CA

Development of rationally designed HIV vaccines

$4,231,061
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$4,230,994
Marianne Buchelli · Connecticut State Dept Of Public Health · U62 · FY2014 · PS

The RCMI Program in Health Disparities Research at Meharry Medical College

$4,230,814
Samuel E. Adunyah · Meharry Medical College · U54 · FY2020 · MD

The Center for HIV RNA Studies (CRNA)

$4,229,079
Alice Telesnitsky · University Of Michigan At Ann Arbor · P50 · FY2016 · GM

Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit

$4,228,318
Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2020 · AI

Development of ALG-097431 as a broad-spectrum 3CL pro inhibitor

$4,228,031
Julian A Symons · Hackensack University Medical Center · U19 · FY2022 · AI

Southern California Primary Infection Program

$4,225,560
University Of California San Diego · U01 · FY2005 · AI

PS10-1001, HIV PREVENTION PROJECTS

$4,223,900
Mildred Williamson · Illinois State Dept Of Public Health · U62 · FY2011 · PS

Neuropathogenesis of Retroviral Infections

$4,223,061
Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS

RAPID ACCELERATION OF DIAGNOSTICS AWARD MANAGEMENT - HIV WP2 AWARDS

$4,221,341
Rebekah Neal · Venturewell · N01 · FY2025 · HL

HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA

$4,219,438
Grace John-Stewart · University Of Washington · U62 · FY2008 · PS

Project 2: PanbetaCoV protein vaccine design

$4,217,384
Kevin Wiehe · Duke University · P01 · FY2021 · AI